NCR201

· Nuwacell Biotechnologies Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCR201, covering 2025-08-01 to 2025-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease [Phase 1]

See pricing